Swiss GastroTalk: Treat-to-Target follow-up with live Q&A

KEYVISUAL Gastro Talks grau

Quickfacts

November 10, 2026
18:00–19:30
Online Webinar (live Q&A)
English
Gastroenterology
Kostenlos

Welcome to the Swiss GastroTalk follow-up with live Q&A! 

Following our successful webcast on "Treat-to-Target," we are exited to invite you to this interactive follow-up session. 

To get the most out of this live discussion, we highly recommend watching the 1-hour webcast recording in our library before joining us. Clinical practice is dynamic, and complex patient cases often raise practical questions that go beyond standard guidelines. This is your opportunity to bring those specific clinical challenges and real-world scenarios directly to our expert panel. Whether you want to dive deeper into the webcast topics or discuss new case management strategies, your questions will drive our live conversation. Participation is free, but registration is required, secure your spot today to receive your access link and join the conversation!

Follow-up live Q&A based on the topics discussed during the SwissGastro Talk from 28th May 2026.

Topics:

  • The limitations of the classic Treat-to-Target approach and exclusive insights into STRIDE III
  • First-Line Biologics (IFX & Vedolizumab)
  • The Evolution of Treat-to-Target & PROFILE Study
  • Subcutaneous Infliximab (IFX SC) & Pharmacokinetics
  • Intestinal Ultrasound (IUS) in Daily Practice
  • Biosimilars, Treatment Costs & First-Line Positioning
  • Decision-Making & Parameter Weighting in Daily Practice

Experts

NEW alain schoepfer square

Prof. Dr. med.
Alain Schoepfer

Médecin chef, CHUV

Schreiber Stefan square

Prof. Dr. med. Dr. h. c.
Stefan Schreiber

Universitätsklinikum Schleswig-Holstein

Unknown

This event is financially supported by the following companies. The scientific programme and content are developed independently and without any influence from the supporting companies.

Sponsor

Main Sponsor

Partner